Last Updated: 20/10/2014
Evaluation of safety and efficacy of two primaquine dosing regimens for the radical treatment of P. vivax malaria in Vanuatu and Solomon Islands
Objectives
To compare the efficacy of standard (0.25mg/kg/day for 14 days) and high-dose (0.5mg/kg/day for 14 days) primaquine in preventing early relapses from P. vivax in the Solomon Islands and Vanuatu.
Principal Institution
Walter and Eliza Hall Institute of Medical Research (WEHI), Australia
Principal Investigators / Focal Persons
Date
Apr 2013 — May 2015
Total Project Funding
$104,090
Funding Details
Project Site
Related Resources
